The many faces of telomerase: Emerging extratelomeric effects

BioEssays

Volumn 30, Issue 8, 2008, Pages 728-732

  Bollmann, F Mathias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CATALYSIS; CELL DIVISION; CELL VIABILITY; CHROMOSOME; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; REVIEW; TELOMERE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CHROMOSOMES; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; RNA; RNA-DIRECTED DNA POLYMERASE; STEM CELLS; TELOMERASE; TELOMERE;

EID: 48949085109     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20793     Document Type: Review

References (50)

1. Richter T, Zglinicki T. 2007. A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol 42:1039-1042.
2. Olovnikov AM. 1973. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41:181-190.
3. Shay JW, Wright WE. 2004. Telomeres are double-strand DNA breaks hidden from DNA damage responses. Mol Cell 14:420-421.
4. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, et al. 1997. Human telomerase contains evolutionary conserved catalytic and structural subunits. Genes Dev 11:3109-3115.
5. Burger AM. 1999. Telomerase in cancer diagnosis and therapy: a clinical perspective. BioDrugs 12:413-422.
6. Herrera E, Martinez AC, Blasco MA. 2000. Impaired germinal center reaction in mice with short telomeres. EMBO J 19:472-481.
7. Liu L, Bailey SM, Okuka M, Munoz P, Li C, et al. 2007. Telomere lengthening early in development. Nat Cell Biol 9:1436-1441.
8. Chung HK, Cheong C, Song J, Lee HW. 2005. Extratelomeric functions of telomerase. Curr Mol Med 5:233-241.
9. De Semir D, Nosrati M, Li S, Kashani-Sabet M. 2007. Telomerase: going beyond the ends. Cell Cycle 6:546-549.
10. Johnson JE, Broccoli D. 2007. Telomere maintenance in sarcomas. Curr Opin Oncol 19:377-382.
11. Hector RE, Shtofman RL, Ray A, Chen BR, Nyun T, et al. 2007. Tel1p preferentially associates with short telomeres to stimulate their elongation. Mol Cell 27:851-858.
12. Benetti R, Garcia-Cao M, Blasco MA. 2007. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 39:243-250.
13. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. 2003. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 17:88-100.
14. Canela A, Martin-Caballero J, Flores JM, Blasco MA. 2004. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 24: 4275-4293.
15. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al. 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99:12520-12522.
16. Sun B, Chen M, Hawks CL, Hornsby PJ. 2005. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation. Cancer Res 65:6512-6515.
17. Kim JW, Dang CV. 2006. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-8930.
18. Bratslavsky G, Sudarshan S, Neckers L, Linehan WM. 2006. Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res 13:4667-4671.
19. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, et al. 2004. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24:6076-6083.
20. Nergadze SG, Santagostino M, Salzano A, Mondello C, Giulotto E. 2007. Contribution of telomerase RNA retrotranscription to DNA double-strand break repair during mammalian genome evolution. Genome Biol 8:R260.
21. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, et al. 2005. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. ProcNatl Acad Sci USA 102:8222-8227.
22. Smith LL, Coller HA, Roberts JM. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-479.
23. Geserick C, Tejera A, Gonzalez-Suarez E, Klatt P, Blasco MA. 2006. Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25:4310-4319.
24. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, et al. 2001. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20:2619-2630.
25. Maser RS, DePinho RA. 2002. Keeping telomerase in its place. Nat Med 8:934-936.
26. Hertzog Santos J, Meyer JN, Skorvaga M, Annab LA, van Houten B. 2004. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 3:399-411.
27. Hertzog Santos J, Meyer JN, van Houten B. 2006. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15: 1757-1768.
28. Haendeler J, Hoffmann J, Brandes RP, Zeiher AM, Dimmeler S. 2003. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 23:4598-4610.
29. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, et al. 2008. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121:1046-1053.
30. Zhu H, Fu W, Mattson MP. 2000. The catalytic subunit of telomerase protects neurons against amyloid β-peptide-induced apoptosis. J Neurochem 75:117-124.
31. Kang HJ, Choi YS, Hong SB, Kim KW, Woo RS, et al. 2004. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J Neurosci 24:1280-1287.
32. Mattson MP, Fu W, Zhang P. 2001. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev 122:659-671.
33. Folini M, Bandiera R, Millo E, Gandellini P, Sozzi G, et al. 2007. Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells. Cell Prolif 40:905-920.
34. Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, et al. 2006. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Cancer Res 66:3584-3592.
35. Xi L, Chen G, Zhou J, Xu G, Wang S, et al. 2006. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis 11:789-798.
36. Dudognon C, Pendino F, Hillion J, Saumet A, Lanotte M, et al. 2004. Death receptor signalling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance. Oncogene 23:7469-7474.
37. Cao Y, Li H, Deb S, Liu JP. 2002. TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21:3130-3138.
38. Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, et al. 2007. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function. Cell Death Diff 12:1429-1438.
39. Rahman R, Latonen L, Wiman KG. 2005. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 24:1320-1327.
40. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, et al. 2005. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-1052.
41. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, et al. 2008. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PloS Genet 4:e10.
42. Kedde M, le Sage C, Duursma A, Zlotorynski E, van Leeuwen B, et al. 2006. Telomerase-independent regulation of ATR by human telomerase RNA. J Biol Chem 281:40503-40514.
43. Blasco MA, Rizen M, Greider CW, Hanahan D. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12:200-204.
44. Bachor C, Bachor OA, Boukamp P. 1999. Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 125:453-460.
45. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, et al. 1996. Telomerase activity in normal human epithelial cells. Oncogene 13:433-439.
46. Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, et al. 2004. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Int J Oncol 24:879-884.
47. Nagao K, Ohyashiki JH, Ohyashiki K, Tabata K, Takai K, et al. 2005. Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity. Int J Mol Med 15:683-688.
48. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al. 2003. Telomerase maintains telomere structure in normal human cells. Cell 114:241-253.
49. Zimmermann S, Glaser S, Ketteler R, Waller CF, Klingmüller U, Martens UM. 2004. Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells 22:741-749.
50. Wang JC, Warner JK, Erdmann N, Lansdorp PM, Harrington L, Dick JE. 2005. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc Natl Acad Sci USA 102:14398-14403.